Sequencing Reagents Market Sequencing Reagents Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology (Next Generation Sequencing, Sanger Sequencing, and Third Generation Sequencing); Application (Agrigenomics and Forensics, Clinical Investigation, Oncology, Reproductive Health, and Other Applications); Reagent Type (Control Kits, Library Kits, Template Kits, Sequencing Kits, and Other Reagent Types); End User (Hospitals and Clinics, Research Institutes, Pharmaceutical and Biotechnology Companies, and Other End Users); Geography.
Current and future Market Scenario According to our new market research study on “Sequencing Reagents Market to 2027 – Global Analysis and Forecast – by Type, Treatment, and End User,” the market was valued at US$ 5,530.32 million in 2020 and is projected to reach US$ 14,195.60 million by 2028; it is expected to grow at a CAGR of 12.5% from 2020 to 2028. The factors such as growing funding for genomics, declining cost of sequencing procedures, and increasing prevalence of chronic diseases drive the growth of the global sequencing reagents market. However, the dearth of skilled professionals hinders the market growth. Sequencing Reagents Market
Market Segments Sequencing Reagents Market By OtherSequencingTemplateLibraryControlTypeKitsKitsKitsKitsReagentTypes By End HospitalsUserand Clinics Research OtherBiotechnologyPharmaceuticalInstitutesandCompaniesEndUsers By AgrigenomicsApplicationand Forensics Clinical OtherReproductiveOncologyInvestigationHealthApplications
Leading Players Sequencing Reagents Market Company Profiles in Sequencing Reagents Market are: BGI Group F. Hoffmann-La Roche Ltd. FluidigmIllumina,CorporationInc. LGC Biosearch Technologies Pacific Biosciences of California, Inc. TakaraQiagenBio, Inc. Thermo Fisher Scientific, Inc. Trilink Biotechnologies
Thank You! Sequencing ReagentsAccessMarketFull Research Report at: https://www.theinsightpartners.com/reports/sequencing-reagents-market Thank You!
